Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Klotho protein is a type I transmembrane glycoprotein predominantly produced in the kidney and expressed in other tissues. It functions as a co-receptor for FGF23, regulating mineral metabolism. It is considered an anti-aging factor and has anti-inflammatory and antioxidant properties. Soluble Klotho serves as a biomarker for aging, kidney function, and inflammation, and is being explored as a potential therapeutic target.
Acts as a co-receptor for FGF23, regulating phosphate excretion, vitamin D metabolism, and calcium reabsorption. Modulates ion channel activity. Inhibits insulin/IGF-1 and Wnt signaling pathways. Activates antioxidant pathways and suppresses inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Klotho Protein (KL).